Loading clinical trials...
Loading clinical trials...
A Phase III Randomized Study of SU101 Versus Procarbazine for Patients With Glioblastoma Multiforme in First Relapse
Conditions
Interventions
leflunomide
procarbazine hydrochloride
Locations
35
United States
St. Joseph's Hospital and Medical Center
Phoenix, Arizona, United States
Arizona Cancer Center
Tucson, Arizona, United States
USC/Norris Comprehensive Cancer Center
Los Angeles, California, United States
Jonsson Comprehensive Cancer Center, UCLA
Los Angeles, California, United States
Beckman Research Institute, City of Hope
Los Angeles, California, United States
St. Francis Hospital
San Francisco, California, United States
Start Date
February 1, 1998
Primary Completion Date
May 1, 2001
Completion Date
May 1, 2001
Last Updated
September 11, 2012
NCT00602667
NCT00683319
NCT07416188
NCT00897286
NCT06742593
NCT00884598
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions